Back to Search
Start Over
US FDA grants orphan drug status to BRIM Biotechnology's BRM424 to treat neurotrophic keratitis
- Source :
- PharmaBiz. December 12, 2022
- Publication Year :
- 2022
-
Abstract
- BRIM Biotechnology, Inc., a company established in July 2013 to accelerate the development and transformation of early research technology platforms to clinical drug candidates, announced that the US Food and [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.729715064